254 related articles for article (PubMed ID: 29262668)
1. Testicular cancer from diagnosis to epigenetic factors.
Boccellino M; Vanacore D; Zappavigna S; Cavaliere C; Rossetti S; D'Aniello C; Chieffi P; Amler E; Buonerba C; Di Lorenzo G; Di Franco R; Izzo A; Piscitelli R; Iovane G; Muto P; Botti G; Perdonà S; Caraglia M; Facchini G
Oncotarget; 2017 Nov; 8(61):104654-104663. PubMed ID: 29262668
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic markers for germ cell neoplasms: from placental-like alkaline phosphatase to micro-RNAs.
Rajpert-De Meyts E; Nielsen JE; Skakkebaek NE; Almstrup K
Folia Histochem Cytobiol; 2015; 53(3):177-88. PubMed ID: 26306513
[TBL] [Abstract][Full Text] [Related]
3. An up-date on epigenetic and molecular markers in testicular germ cell tumors.
Chieffi P
Intractable Rare Dis Res; 2017 Nov; 6(4):319-321. PubMed ID: 29259864
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of markers M2A, OCT3/4, AP-2gamma, PLAP and c-KIT in the detection of extragonadal seminomas.
Biermann K; Klingmüller D; Koch A; Pietsch T; Schorle H; Büttner R; Zhou H
Histopathology; 2006 Sep; 49(3):290-7. PubMed ID: 16918976
[TBL] [Abstract][Full Text] [Related]
5. On the Origin of Testicular Germ Cell Tumors: From Gonocytes to Testicular Cancer.
Baroni T; Arato I; Mancuso F; Calafiore R; Luca G
Front Endocrinol (Lausanne); 2019; 10():343. PubMed ID: 31244770
[TBL] [Abstract][Full Text] [Related]
6. Transcription factor AP-2gamma is a developmentally regulated marker of testicular carcinoma in situ and germ cell tumors.
Hoei-Hansen CE; Nielsen JE; Almstrup K; Sonne SB; Graem N; Skakkebaek NE; Leffers H; Rajpert-De Meyts E
Clin Cancer Res; 2004 Dec; 10(24):8521-30. PubMed ID: 15623634
[TBL] [Abstract][Full Text] [Related]
7. Trials of new germ cell immunohistochemical stains in 93 extragonadal and metastatic germ cell tumors.
Iczkowski KA; Butler SL; Shanks JH; Hossain D; Schall A; Meiers I; Zhou M; Torkko KC; Kim SJ; MacLennan GT
Hum Pathol; 2008 Feb; 39(2):275-81. PubMed ID: 18045648
[TBL] [Abstract][Full Text] [Related]
8. [Embryonal germ cells and germ cell tumors].
Biermann K; Heukamp LC; Nettersheim D; Steger K; Zhou H; Franke FE; Guetgemann I; Sonnack V; Brehm R; Berg J; Bastian PJ; Müller SC; Wang-Eckert L; Schorle H; Büttner R
Verh Dtsch Ges Pathol; 2007; 91():39-48. PubMed ID: 18314594
[TBL] [Abstract][Full Text] [Related]
9. Embryonic stem cell transcription factor signatures in the diagnosis of primary and metastatic germ cell tumors.
Santagata S; Ligon KL; Hornick JL
Am J Surg Pathol; 2007 Jun; 31(6):836-45. PubMed ID: 17527070
[TBL] [Abstract][Full Text] [Related]
10. Origin of pluripotent germ cell tumours: the role of microenvironment during embryonic development.
Kristensen DM; Sonne SB; Ottesen AM; Perrett RM; Nielsen JE; Almstrup K; Skakkebaek NE; Leffers H; Rajpert-De Meyts E
Mol Cell Endocrinol; 2008 Jun; 288(1-2):111-8. PubMed ID: 18420341
[TBL] [Abstract][Full Text] [Related]
11. Spontaneous regression of testicular germ cell tumors: an analysis of 42 cases.
Balzer BL; Ulbright TM
Am J Surg Pathol; 2006 Jul; 30(7):858-65. PubMed ID: 16819328
[TBL] [Abstract][Full Text] [Related]
12. Embryonic stem cell transcription factors and D2-40 (podoplanin) as diagnostic immunohistochemical markers in ovarian germ cell tumors.
Chang MC; Vargas SO; Hornick JL; Hirsch MS; Crum CP; Nucci MR
Int J Gynecol Pathol; 2009 Jul; 28(4):347-55. PubMed ID: 19483629
[TBL] [Abstract][Full Text] [Related]
13. New evidence for the origin of intracranial germ cell tumours from primordial germ cells: expression of pluripotency and cell differentiation markers.
Hoei-Hansen CE; Sehested A; Juhler M; Lau YF; Skakkebaek NE; Laursen H; Rajpert-de Meyts E
J Pathol; 2006 May; 209(1):25-33. PubMed ID: 16456896
[TBL] [Abstract][Full Text] [Related]
14. Developmental model for the pathogenesis of testicular carcinoma in situ: genetic and environmental aspects.
Rajpert-De Meyts E
Hum Reprod Update; 2006; 12(3):303-23. PubMed ID: 16540528
[TBL] [Abstract][Full Text] [Related]
15. POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors.
Looijenga LH; Stoop H; de Leeuw HP; de Gouveia Brazao CA; Gillis AJ; van Roozendaal KE; van Zoelen EJ; Weber RF; Wolffenbuttel KP; van Dekken H; Honecker F; Bokemeyer C; Perlman EJ; Schneider DT; Kononen J; Sauter G; Oosterhuis JW
Cancer Res; 2003 May; 63(9):2244-50. PubMed ID: 12727846
[TBL] [Abstract][Full Text] [Related]
16. Circulating serum miRNA (miR-367-3p, miR-371a-3p, miR-372-3p and miR-373-3p) as biomarkers in patients with testicular germ cell cancer.
Syring I; Bartels J; Holdenrieder S; Kristiansen G; Müller SC; Ellinger J
J Urol; 2015 Jan; 193(1):331-7. PubMed ID: 25046619
[TBL] [Abstract][Full Text] [Related]
17. A novel double staining strategy for improved detection of testicular carcinoma in situ cells in human semen samples.
Nielsen JE; Kristensen DM; Almstrup K; Jørgensen A; Olesen IA; Jacobsen GK; Horn T; Skakkebaek NE; Leffers H; Rajpert-De Meyts E
Andrologia; 2012 Apr; 44(2):78-85. PubMed ID: 21486421
[TBL] [Abstract][Full Text] [Related]
18. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
Ulbright TM
Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
[TBL] [Abstract][Full Text] [Related]
19. Identification of germ cells at risk for neoplastic transformation in gonadoblastoma: an immunohistochemical study for OCT3/4 and TSPY.
Kersemaekers AM; Honecker F; Stoop H; Cools M; Molier M; Wolffenbuttel K; Bokemeyer C; Li Y; Lau YF; Oosterhuis JW; Looijenga LH
Hum Pathol; 2005 May; 36(5):512-21. PubMed ID: 15948118
[TBL] [Abstract][Full Text] [Related]
20. Distinct epigenetic phenotypes in seminomatous and nonseminomatous testicular germ cell tumors.
Smiraglia DJ; Szymanska J; Kraggerud SM; Lothe RA; Peltomäki P; Plass C
Oncogene; 2002 May; 21(24):3909-16. PubMed ID: 12032829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]